Syntellix, the world's leading supplier of highly innovative magnesium-based implants for orthopaedics and trauma surgery, has reached another important milestone. The Philippine Food and Drug Administration (FDA) has granted Syntellix AG the registration of the full MAGNEZIX^® CBS screw portfolio, making the Philippines the 67^th country that allows for import and sale of MAGNEZIX^® implants.

Having this at hand, Syntellix is enthusiastic to scale up its business operations, bundled in its local subsidiary Syntellix Philippines Inc., and introduce an increasing number of medical devices to the Southeast Asian archipelago for the benefit of the Philippine patients, doctors, healthcare providers and society.

-> Go to press release